speaker photo

John McCamant

Editor

Medical Technology Stock Letter

John McCamant was named editor of the Medical Technology Stock Letter in August 2000. He has spent 35 years on the front lines of biotechnology investing as an equities analyst and in venture capital. His expertise in biotechnology investments is a subject of media interest, and he is frequently consulted and quoted by The Washington Post, BusinessWeek, Reuters, and Bloomberg.


Watch On-Demand

Get the Virtual Pass to Watch 30+ Sessions On-Demand!

Speaker Schedule

Thursday, September 8, 2022 - 1:35 pm to 2:05 pm EDT Back to School: Biotech Stocks That Are Poised for Big Moves Focus: STOCKS

Join John McCamant for this in-depth session, designed to bring you the latest intelligence available so you can identify and profit from the opportunities in today's markets. The knowledge you gain by attending this session can help you make better investing or trading decisions tomorrow.

RESERVE YOUR FREE PASS TODAY
MoneyShow

For questions please contact our Client Relations Team at 800-970-4355 or 941-955-0323.

Social Updates

Follow us on social media to stay in the loop as more great speakers are added to the schedule!